The US drug regulator is conducting audits at Sun Pharma's Halol facility in Gujarat. Sun had recalled multiple products made in this facility. Could this spell further trouble for Sun Pharma? Pharma Asia News India bureau chief Vikas Dandekar spoke with CNBC-TV18‘s Senthil Chengalvarayan and Sonia Shenoy to discuss the development.
first published: Sep 11, 2014 06:48 pm
A collection of the most-viewed Moneycontrol videos.
Live: Banking stocks fuel Nifty above 24,500; Uncertainty persists on US-Iran talks | Closing Bell
JD Vance May Visit Pakistan For Second Round Of Peace Talks With Iran: Reports
Trump Claims Iran N-Sites ‘Obliterated’: ‘Digging Nuclear Dust Won’t Be Easy’
PAN Misuse Alert | How to Check If Someone Opened Bank Accounts in Your Name
